Cargando…
Unique In Vitro and In Vivo Thrombopoietic Activities of Ingenol 3,20 Dibenzoate, A Ca(++)-Independent Protein Kinase C Isoform Agonist
Thrombopoiesis following severe bone marrow injury frequently is delayed, thereby resulting in life-threatening thrombocytopenia for which there are limited treatment options. The reasons for these delays in recovery are not well understood. Protein kinase C (PKC) agonists promote megakaryocyte diff...
Autores principales: | Racke, Frederick K., Baird, Maureen, Barth, Rolf F., Huo, Tianyao, Yang, Weilian, Gupta, Nilendu, Weldon, Michael, Rutledge, Heather |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3528756/ https://www.ncbi.nlm.nih.gov/pubmed/23284657 http://dx.doi.org/10.1371/journal.pone.0051059 |
Ejemplares similares
-
Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors
por: Yang, Weilian, et al.
Publicado: (2014) -
Thrombopoietic stimulating activity of rhTyrRS (Y341A)
por: Jinchao, Yu, et al.
Publicado: (2017) -
Systematic literature review and meta-analysis on use of Thrombopoietic agents for chemotherapy-induced thrombocytopenia
por: Soff, Gerald A., et al.
Publicado: (2022) -
Ingenol mebutate treatment in keloids
por: De Felice, Bruna, et al.
Publicado: (2015) -
Tattoo removal with ingenol mebutate
por: Cozzi, Sarah-Jane, et al.
Publicado: (2017)